Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-29

Clinical Trial Update: The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia

View source ↗

Summary

This clinical trial investigates the use of allogeneic hematopoietic stem cell transplantation in newly diagnosed high-relapse-risk CEBPA-mutant acute myeloid l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ruijin Hospital | Conditions: Acute Myeloid Leukemia | Status: RECRUITING